First Header Logo Second Header Logo


Kathleen Hayden to Genetic Predisposition to Disease

This is a "connection" page, showing publications Kathleen Hayden has written about Genetic Predisposition to Disease.
  1. Hayden KM, McEvoy JM, Linnertz C, Attix D, Kuchibhatla M, Saunders AM, Lutz MW, Welsh-Bohmer KA, Roses AD, Chiba-Falek O. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimers Dement. 2012 Sep; 8(5):381-8.
    View in: PubMed
    Score: 0.329
  2. Hayden KM, Zandi PP, West NA, Tschanz JT, Norton MC, Corcoran C, Breitner JC, Welsh-Bohmer KA. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Arch Neurol. 2009 Nov; 66(11):1378-83.
    View in: PubMed
    Score: 0.272
  3. Hayden KM, Lutz MW, Kuchibhatla M, Germain C, Plassman BL. Effect of APOE and CD33 on Cognitive Decline. PLoS One. 2015; 10(6):e0130419.
    View in: PubMed
    Score: 0.100
  4. Vu THT, Beck T, Bennett DA, Schneider JA, Hayden KM, Shadyab AH, Rajan KB, Morris MC, Cornelis MC. Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts. Nutrients. 2022 Jul 03; 14(13).
    View in: PubMed
    Score: 0.041
  5. Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, Strittmatter WJ, Burke JR, Hulette CM, Welsh-Bohmer KA, Goldstein DB. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis. 2010; 19(1):69-77.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.